Article
AI-guided design of a CXCR4-targeted core–shell nanocarrier for co-delivery of berberine/paclitaxel in cancer therapy
2025-08-14
Abstract excerpt
<title>Abstract</title> <p>An integrated three-step artificial-intelligence (AI) workflow was used to accelerate the design of a CXCR4-targeted, dual-drug nanocarrier for colorectal-cancer therapy. First, the MD-Syn platform screened 38 approved oncology agents across six human colorectal-cancer cell lines (HCT116, HT29, LoVo, RKO, SW620, SW837) and identified paclitaxel (PTX) as the compound with a > 0.9999 prob...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- db623cfe-30df-5177-957b-4fbc23cdf546
- DOI
- 10.21203/rs.3.rs-7307122/v1
